Age (years) |
67 (58–76) |
Female (%) |
89 (36.3) |
Male (%) |
155 (63.5) |
Number of percutaneous procedures |
553 |
PTE-RV |
163 (29.5) |
PTC |
390 (70.5) |
Main diagnosis (%) |
|
Malignancy |
174 (71.3) |
Metastatic disease |
85 (48.9) |
Entities of carcinoma |
|
Pancreas-carcinoma |
57 (32.8) |
Cholangio-carcinoma |
33 (19.0) |
Gastric-carcinoma |
31 (17.8) |
Metastatic colorectal-carcinoma |
16 (9.2) |
Papillary-carcinoma |
7 (4.0) |
Gallbladder-carcinoma |
5 (2.9) |
Other carcinoma (local or metastatic) |
25 (14.3) |
Benignancy |
70 (28.6) |
Entities of benignancy |
|
Cholelithiasis |
32 (45.7) |
Postoperative biliodigestive anastomotic stricture |
22 (31.4) |
Acute and chronic pancreatitis |
5 (7.1) |
Sclerosing cholangitis |
4 (5.7) |
Postoperative biliary leakage |
3 (4.3) |
Anastomotic stricture and choledocholithiasis |
3 (4.3) |
Juxtapapillary diverticulum |
1 (1.4) |
Postoperative changes of bowel anatomy (%) |
|
Patients with an altered postoperative bowel anatomy |
124 (50.8) |
Billroth operation II |
36 (29.0) |
Gastrectomy |
28 (22.6) |
Biliodigestive anastomosis |
20 (16.1) |
Whipple and Traverso-Longmire operation |
14 (11.3) |
Gastroenteric anastomosis |
11 (8.9) |
Others |
15 (12.1) |